Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.

Mäkitie, Riikka E; Kämpe, Anders; Costantini, Alice; Alm, Jessica J; Magnusson, Per; Mäkitie, Outi

Mäkitie, Riikka E; Kämpe, Anders; Costantini, Alice; Alm, Jessica J; Magnusson, Per; Mäkitie, Outi.

Afiliação

Mäkitie RE; Faculty of Medicine, Folkhälsan Institute of Genetics and Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland.
Kämpe A; Molecular Endocrinology Laboratory, Department of Medicine, Hammersmith Campus, Imperial College London, London, UK.
Costantini A; Department of Molecular Medicine and Surgery, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Alm JJ; Clinical Genetics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Magnusson P; Department of Molecular Medicine and Surgery, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Mäkitie O; Department of Molecular Medicine and Surgery, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

J Bone Miner Res ; 35(5): 901-912, 2020 05.

Article em En | MEDLINE | ID: mdl-31968132

Assuntos

Fatores de Crescimento de Fibroblastos; Osteoporose; Biomarcadores; Densidade Óssea; Osso e Ossos; Fator de Crescimento de Fibroblastos 23; Fatores de Crescimento de Fibroblastos/genética; Humanos; Peptídeos e Proteínas de Sinalização Intercelular/genética; Osteoporose/genética; Via de Sinalização Wnt

Palavras-chave

DICKKOPF-1; FIBROBLAST GROWTH FACTOR 23; OSTEOPOROSIS; PLS3; SCLEROSTIN; WNT SIGNALING

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Fatores de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google